Healthier Markets. Healthier Lives.

Innovative finance for affordable and accessible healthcare

We are a social finance company with a difference. We are motivated by purpose, not profit.

Using innovative finance tools, we secure lower prices and sustainable supply of medical products for people in low- and middle-income countries. Our work combines commercial insight and rigour with a relentless pursuit of health impact.

MedAccess is an independent company, wholly owned by the UK’s CDC Group plc.

OUR IMPACT

Read our 2020 Annual Report

COVID-19 brought the extent and consequences of unequal access to healthcare into sharp focus. Find out how our partnerships are increasing access to life-saving healthcare products.

Find out more

Two scientists using a Hologic Panther machine

ABOUT US

Who we are

We believe in a world where everyone can access the medicines and healthcare products they need to lead healthy lives.

Learn more

OUR WORK

Innovative finance for development

Our innovative finance tools enable manufacturers and procurers to enter into partnerships that increase access to medical products for people who need them.

Learn more

Latest News & Insight

Insight – 01 Dec '21

HIV viral load testing: “If we could test more often, we would”

HIV viral load testing is the best way for doctors to know if the treatment they prescribe is effective. But access to viral load testing technology is far from equal.

Insight – 16 Nov '21

Five things you should know about the new partnership to increase access to dual HIV/syphilis testing

On November 15, the Clinton Health Access Initiative (CHAI), MedAccess, and SD Biosensor announced a partnership to increase access to rapid diagnostic tests for syphilis and HIV.

News – 15 Nov '21

New partnership to increase access to dual rapid testing for syphilis and HIV

MedAccess, CHAI and SD Biosensor announce partnership to make dual rapid test for syphilis and HIV available for under US$1 in over 100 low- and middle-income countries

Insight – 19 Oct '21

“I know first-hand the importance of patient-friendly TB treatment”

Evans Mburu, our implementation executive, knows first-hand TB’s devastating impact. Watch Evans share his story about taking TB treatment.